SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Linden Daniel)
 

Search: WFRF:(Linden Daniel) > PPARalpha activatio...

PPARalpha activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes.

Edvardsson, Ulrika, 1967 (author)
Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Wallenberg Laboratory
Ljungberg, Anna, 1977 (author)
Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Wallenberg Laboratory
Lindén, Daniel, 1971 (author)
Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Wallenberg Laboratory
show more...
William-Olsson, Lena (author)
Peilot-Sjögren, Helena, 1974 (author)
Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Wallenberg Laboratory
Ahnmark, Andrea (author)
Oscarsson, Jan, 1960 (author)
Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Wallenberg Laboratory
show less...
 (creator_code:org_t)
2006
2006
English.
In: Journal of lipid research. - 0022-2275. ; 47:2, s. 329-40
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Adipose differentiation-related protein (ADRP) is a lipid droplet-associated protein that is expressed in various tissues. In mice treated with the peroxisome proliferator-activated receptor alpha (PPARalpha) agonist Wy14,643 (Wy), hepatic mRNA and protein levels of ADRP as well as hepatic triglyceride content increased. Also in primary mouse hepatocytes, Wy increased ADRP expression and intracellular triglyceride mass. The triglyceride mass increased in spite of unchanged triglyceride biosynthesis and increased palmitic acid oxidation. However, Wy incubation decreased the secretion of newly synthesized triglycerides, whereas apolipoprotein B secretion increased. Thus, decreased availability of triglycerides for VLDL assembly could help to explain the cellular accumulation of triglycerides after Wy treatment. We hypothesized that this effect could be mediated by increased ADRP expression. Similar to PPARalpha activation, adenovirus-mediated ADRP overexpression in mouse hepatocytes enhanced cellular triglyceride mass and decreased the secretion of newly synthesized triglycerides. In ADRP-overexpressing cells, Wy incubation resulted in a further decrease in triglyceride secretion. This effect of Wy was not attributable to decreased cellular triglycerides after increased fatty acid oxidation because the triglyceride mass in Wy-treated ADRP-overexpressing cells was unchanged. In summary, PPARalpha activation prevents the availability of triglycerides for VLDL assembly and increases hepatic triglyceride content in part by increasing the expression of ADRP.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Fysiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Physiology (hsv//eng)

Keyword

Acyl-CoA Dehydrogenase
Long-Chain
genetics
Acyl-CoA Oxidase
genetics
Animals
Apolipoprotein B-100
Apolipoprotein B-48
Apolipoproteins B
secretion
Carnitine O-Palmitoyltransferase
genetics
Dietary Fats
administration & dosage
pharmacology
Gene Expression
drug effects
genetics
Hepatocytes
drug effects
metabolism
secretion
Liver
drug effects
metabolism
Membrane Proteins
genetics
metabolism
Mice
Mice
Inbred C57BL
Mice
Knockout
Oxidation-Reduction
PPAR alpha
antagonists & inhibitors
genetics
metabolism
Palmitic Acid
metabolism
Peroxisome Proliferators
pharmacology
Pyrimidines
pharmacology
Transfection
Triglycerides
biosynthesis
metabolism
secretion

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view